Eton Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Eton Pharmaceuticals

09/05/2024 23:10

* Eton Pharmaceuticals Inc  ETON.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -10 cents.  The mean expectation of two analysts
for the quarter was for a loss of 7 cents per share. 
    * Revenue rose 50.2% to $7.97 million from a year ago;
analysts
expected $8.00 million. 
    * Eton Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 3 cents​.
    * The company reported a quarterly loss of $811 thousand.
    * Eton Pharmaceuticals Inc shares had fallen by 0.8% this
quarter and lost 15.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 250%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $8.00 
This summary was machine generated from LSEG data May 9 at 10:09
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.07          -0.03          Beat
 Dec. 31 2023      -0.04          -0.09          Missed
 Sep. 30 2023      -0.10          -0.02          Beat
 Jun. 30 2023      -0.09          0.15           Beat